×
About 238,338 results

ALLMedicine Type 2 Diabetes Center

Research & Reviews  106,773 results

GIP as a therapeutic target in diabetes and obesity: insight from incretin co-agonists.
https://doi.org/10.1210/clinem/dgaa327
The Journal of Clinical Endocrinology and Metabolism; Holst JJ, Rosenkilde MM

May 27th, 2020 - The two hormones responsible for the amplification of insulin secretion after oral as opposed to intravenous nutrient administration are the gut peptides, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Howe...

Evaluation of the Prevalence of Sleep Disorder among Patients with Type 2 Diabetes Mell...
https://doi.org/10.2174/1573399816666200527140340
Current Diabetes Reviews; Khorasani ZM, Ravan VR et. al.

May 27th, 2020 - Diabetes is the most common metabolic disease in primary health care. The prevalence and severity of diabetes can be influenced through lifestyle modification. This study was aimed to identify the prevalence of sleep disorders as a modifiable life...

Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-con...
https://doi.org/10.1111/dom.14097
Diabetes, Obesity & Metabolism; Fadini GP, Morieri ML et. al.

May 27th, 2020 - Because other coronaviruses enter the cells by binding to dipeptidyl-peptidase-4 (DPP-4), it has been speculated that DPP-4 inhibitors (DPP-4i) may exert an activity against SARS-CoV-2. In the absence of clinical trial results, we analyzed epidemi...

Laparoscopic Sleeve Gastrectomy for Type 2 Diabetes Mellitus: Long-Term Result and Recu...
https://doi.org/10.1007/s11695-020-04737-4
Obesity Surgery; Lee MH, Almalki OM et. al.

May 27th, 2020 - Laparoscopic sleeve gastrectomy (LSG) is becoming a primary bariatric/metabolic surgical procedure for treating obesity and related type 2 diabetes mellitus (T2D). This study presents the long-term outcome of LSG about the remission and recurrence...

Oxyntomodulin May Distinguish New-Onset Diabetes After Acute Pancreatitis From Type 2 D...
https://doi.org/10.14309/ctg.0000000000000132
Clinical and Translational Gastroenterology; Bharmal SH, Cho J et. al.

May 27th, 2020 - New-onset diabetes is an important sequela of acute pancreatitis, but there are no biomarkers to differentiate it from the much more common type 2 diabetes. The objective was to investigate whether postprandial circulating levels of gut hormones c...

see more →

Guidelines  317 results

Short-Term Consumption of Sucralose with, but Not without, Carbohydrate Impairs Neural and Metabolic Sensitivity to Sugar in Humans
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(20)30057-7
Cell Metabolism; Dalenberg JR,et al

Mar 2nd, 2020 - There is a general consensus that overconsumption of sugar-sweetened beverages contributes to the prevalence of obesity and related comorbidities such as type 2 diabetes (T2D). Whether a similar relationship exists for no- or low-calorie “diet” dr...

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
https://care.diabetesjournals.org/content/43/2/487
Diabetes Care; Buse JB,et al

Dec 18th, 2019 - The American Diabetes Association and the European Association for the Study of Diabetes have briefly updated their 2018 recommendations on management of hyperglycemia, based on important research findings from large cardiovascular outcomes trials...

FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes
https://www.novonordisk-us.com/media/news-releases.html?122974

Oct 21st, 2019 - Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has expanded the label for Fiasp® (insulin aspart injection) 100 u/mL to include use in insulin infusion pumps for the improvement of glycemic control in adults with typ...

Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement ...
https://doi.org/10.1016/j.numecd.2019.07.017
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Pugliese G, Penno G et. al.

Oct 6th, 2019 - This joint document of the Italian Diabetes Society and the Italian Society of Nephrology reviews the natural history of diabetic kidney disease (DKD) in the light of the recent epidemiological literature and provides updated recommendations on an...

Sleeping less than six hours and heart disease, stroke – deadly combo
https://newsroom.heart.org/news/sleeping-less-than-six-hours-and-heart-disease-stroke-deadly-combo

Oct 1st, 2019 - Middle-aged adults with high blood pressure, Type 2 diabetes, heart disease or stroke could be at increased risk for cancer and early death when sleeping less than 6 hours per day.

see more →

Drugs  2,287 results see all →

Clinicaltrials.gov  117,665 results

Glyburide and metformin hydrochloride - glyburide and metformin hydrochloride tablet, film coated-Actavis Pharma, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ace67632-4620-49cf-97c4-c105d2b45097

May 30th, 2020 - Glyburide and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glyburide and metformin hydrochloride tablets are a combination of glyburide, a sul...

GIP as a therapeutic target in diabetes and obesity: insight from incretin co-agonists.
https://doi.org/10.1210/clinem/dgaa327
The Journal of Clinical Endocrinology and Metabolism; Holst JJ, Rosenkilde MM

May 27th, 2020 - The two hormones responsible for the amplification of insulin secretion after oral as opposed to intravenous nutrient administration are the gut peptides, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Howe...

Evaluation of the Prevalence of Sleep Disorder among Patients with Type 2 Diabetes Mell...
https://doi.org/10.2174/1573399816666200527140340
Current Diabetes Reviews; Khorasani ZM, Ravan VR et. al.

May 27th, 2020 - Diabetes is the most common metabolic disease in primary health care. The prevalence and severity of diabetes can be influenced through lifestyle modification. This study was aimed to identify the prevalence of sleep disorders as a modifiable life...

Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-con...
https://doi.org/10.1111/dom.14097
Diabetes, Obesity & Metabolism; Fadini GP, Morieri ML et. al.

May 27th, 2020 - Because other coronaviruses enter the cells by binding to dipeptidyl-peptidase-4 (DPP-4), it has been speculated that DPP-4 inhibitors (DPP-4i) may exert an activity against SARS-CoV-2. In the absence of clinical trial results, we analyzed epidemi...

Laparoscopic Sleeve Gastrectomy for Type 2 Diabetes Mellitus: Long-Term Result and Recu...
https://doi.org/10.1007/s11695-020-04737-4
Obesity Surgery; Lee MH, Almalki OM et. al.

May 27th, 2020 - Laparoscopic sleeve gastrectomy (LSG) is becoming a primary bariatric/metabolic surgical procedure for treating obesity and related type 2 diabetes mellitus (T2D). This study presents the long-term outcome of LSG about the remission and recurrence...

see more →

News  11,215 results

Largest Study to Date Links Glucose Control to COVID-19 Outcomes
https://www.medscape.com/viewarticle/930521

May 13th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The strong link between glucose control and COVID-19 outcomes has been re-affirmed in the largest study thus far of hospitalized patients with pre...

Call for More Transparency in Gray Area of Post-Approval Drug Studies
https://www.medscape.com/viewarticle/930045

May 5th, 2020 - Sodium-glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes "have received several serious safety warnings since approval, but the number, timeliness, and strength of these safety communications have differed between Ame...

Prediabetes and Vascular Disease Risk in Newly Diagnosed T2D
https://www.medscape.com/viewarticle/929938

May 4th, 2020 - Takeaway Microvascular and macrovascular diseases were frequently detected at the time of type 2 diabetes (T2D) diagnosis. Individuals with prior prediabetes were at an increased risk of microvascular disease and acute coronary syndrome at the tim...

SGLT2 Inhibitors May Prevent Diabetic Kidney Disease
https://www.medscape.com/viewarticle/929866

May 3rd, 2020 - Use of the sodium-glucose cotransporter 2 (SGLT2) inhibitor diabetes drug class "may lower the risk of serious renal events in routine clinical practice," new data from a Scandinavian registry indicate. The patients, for the most part, had no kidn...

Light-to-Moderate Alcohol Consumption Tied to Increased Type 2 Diabetes Risk With NAFLD
https://www.medscape.com/viewarticle/929754

Apr 30th, 2020 - (Reuters Health) - People with nonalcoholic fatty liver disease (NAFLD) are at increased risk of developing type 2 diabetes when they consume light-to-moderate amounts of alcohol than when they abstain from drinking, a Chinese study suggests. Rese...

see more →

Patient Education  81 results see all →